Research Topics
Species | Rene AdamSummaryCountry: France Publications
| Collaborators
|
Detail Information
Publications
Long-term results of two-stage hepatectomy for irresectable colorectal cancer liver metastasesDennis A Wicherts
Centre Hepato Biliaire, AP HP Hopital Paul Brousse, Villejuif, France
Ann Surg 248:994-1005. 2008..To assess feasibility, risks, and long-term outcome of 2-stage hepatectomy as a means to improve resectability of colorectal liver metastases (CLM)...
Is perioperative chemotherapy useful for solitary, metachronous, colorectal liver metastases?Rene Adam
Centre Hepato Biliaire, Hopital Paul Brousse, Assistance Publique Hopitaux de Paris, Univ Paris Sud, UMR S 776, Villejuif, France
Ann Surg 252:774-87. 2010..The aim of our study was to address the still pending question of whether perioperative chemotherapy is really beneficial in patients developing solitary metastases at a distance from surgery of the primary...
Liver resection as a bridge to transplantation for hepatocellular carcinoma on cirrhosis: a reasonable strategy?Rene Adam
Centre Hépato Biliare, Hospital Paul Brousse, Assistance Publique, Hospitaux de Paris Université Paris Sud Villejuif, France
Ann Surg 238:508-18; discussion 518-9. 2003..To assess the viability of a strategy of primary resection with secondary liver transplantation (LT) for hepatocellular carcinoma (HCC) on cirrhosis...
Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survivalRene Adam
Centre Hépato Biliaire and Inserm E0354 Cancer Chronotherapeutics, Hopital Paul Brousse, Assistance Publique Hopitaux de Paris Université Paris, Sud Villejuif, France
Ann Surg 240:644-57; discussion 657-8. 2004....
Hepatic colorectal metastases: methods of improving resectabilityRene Adam
Centre Hepato Biliaire, Hopital Paul Brousse, Villejuif, Universite Paris Sud, 14, av P V Couturier, 94800 Villejuif, France
Surg Clin North Am 84:659-71. 2004..To achieve this objective, a close collaboration between oncologists, radiologists, and surgeons is mandatory, with routine re-evaluation of patients for an adequate timing of each treatment...
A comparison of percutaneous cryosurgery and percutaneous radiofrequency for unresectable hepatic malignanciesRene Adam
Department of Hepatobiliary Surgery and Liver Transplantation, Centre Hepato Biliaire, Hopital Paul Brousse, Universite Paris Sud, Villejuif, France
Arch Surg 137:1332-9; discussion 1340. 2002..The complication and success rates in patients treated with either percutaneous cryosurgery (PCS) or percutaneous radiofrequency (PRF) for unresectable hepatic malignancies are similar...
Hepatic resection after down-staging of unresectable hepatic colorectal metastasesRene Adam
Department of Surgery, Centre Hepato Biliaire, Hopital Paul Brousse, 12 avenue Paul Vaillant Couturier, 94804 Villejuif, France
Surg Oncol Clin N Am 12:211-20, xii. 2003..This article reviews the literature and major areas of progress in treatments for unresectable colorectal cancer...
Evolution of liver transplantation in Europe: report of the European Liver Transplant RegistryRene Adam
European Liver Transplant Registry, Villejuif, France
Liver Transpl 9:1231-43. 2003..As with split LT or domino LT, LRLT aims to provide more patients to be transplanted. Special attention is paid to reducing the risk for the donor, which is now estimated to be 0.5% mortality and 21% postoperative morbidity...
[Chemotherapy and surgery in the treatment of liver metastasis of colorectal cancer: a sacred union...]R Adam
, , Villejuif, France
Ann Chir 128:2-4. 2003
Evolution of liver transplantation for hepatocellular carcinomaRene Adam
Centre Hepato Biliaire, Hopital Paul Brousse, Universite Paris Sud, 12 14, avenue Paul Vaillant Couturier, 94804 Villejuif Cedex, France
J Hepatol 39:888-95. 2003
Liver resection for colorectal metastases: the third hepatectomyRene Adam
Centre Hepato Biliaire, Hopital Paul Brousse, 14 Av PV Couturier, 94800 Villejuif, France
Ann Surg 238:871-83; discussion 883-4. 2003..To determine the risk, the benefit, and the main factors of prognosis of third liver resections for recurrent colorectal metastases...
Tumor progression while on chemotherapy: a contraindication to liver resection for multiple colorectal metastases?Rene Adam
Centre Hepato Biliaire, Hopital Paul Brousse, 14 Av PV Couturier, 94800 Villejuif, France
Ann Surg 240:1052-61; discussion 1061-4. 2004..To evaluate the influence of the response to preoperative chemotherapy, especially tumor progression, on the outcome following resection of multiple colorectal liver metastases (CRM)...
Developing strategies for liver metastases from colorectal cancerRene Adam
Hopital Paul Brousse, Assistance Publique Hopitaux de Paris, University Paris Sud 11, 14 avenue Paul Vaillant Couturier, 94800 Villejuif, Paris, France
Semin Oncol 34:S7-11. 2007..This brief report describes data supporting the expanding application of hepatectomy for patients with colorectal liver metastases...
Liver transplantation in Europe: is there a room for improvement?Rene Adam
Hepatobiliary Center, Paul Brousse Hospital, 12 avenue Paul Vaillant Couturier, 94804 Villejuif Cedex, France
J Hepatol 42:33-40. 2005
Five-year survival following hepatic resection after neoadjuvant therapy for nonresectable colorectalR Adam
Centre Hepato Biliaire, Service de Cancérologie Hopital Paul Brousse, Villejuif, France
Ann Surg Oncol 8:347-53. 2001..Our experience with neoadjuvant chemotherapy followed by resection and five years survival analysis of the patients treated is presented...
Normalised intrinsic mortality risk in liver transplantation: European Liver Transplant Registry studyR Adam
ELTR Coordinating Centre, Paul Brousse Hospital, Villejuif, France
Lancet 356:621-7. 2000..We investigated the intrinsic mortality risk in the absence of known mortality risk factors...
Two-stage hepatectomy: A planned strategy to treat irresectable liver tumorsR Adam
Centre Hepato Biliaire, Hopital Paul Brousse, Villejuif, and Université Paris Sud, France
Ann Surg 232:777-85. 2000..To assess feasibility, risks, and patient outcomes in the treatment of colorectal metastases with two-stage hepatectomy...
[Induction chemotherapy and surgery of colorectal liver metastases]Rene Adam
Centre Hepatobiliaire, Hopital Paul Brousse, Universite de Paris Sud, 12, avenue Paul Vaillant Couturier, 94804 Villejuif Cedex
Bull Cancer 93:S45-9. 2006..The objective of this article is to describe this multidisciplinary approach of liver metastases and to report the results of these new strategies...
Tumor marker evolution: comparison with imaging for assessment of response to chemotherapy in patients with colorectal liver metastasesRobbert J de Haas
Centre Hepato Biliaire, AP HP Hopital Paul Brousse, Villejuif, France
Ann Surg Oncol 17:1010-23. 2010....
Regenerative nodular hyperplasia of the liver related to chemotherapy: impact on outcome of liver surgery for colorectal metastasesDennis A Wicherts
Centre Hepato Biliaire, AP HP Hopital Paul Brousse, Villejuif, France
Ann Surg Oncol 18:659-69. 2011..The goal was to evaluate its incidence and impact on the outcome of patients resected for colorectal liver metastases (CLM)...
Cetuximab and circadian chronomodulated chemotherapy as salvage treatment for metastatic colorectal cancer (mCRC): safety, efficacy and improved secondary surgical resectabilityFrancis Levi
INSERM, U776 Rythmes biologiques et cancers, Hopital Paul Brousse, 14 avenue Paul Vaillant Couturier, 94807 Villejuif Cedex, France
Cancer Chemother Pharmacol 67:339-48. 2011..We hypothesized that EGFR blockade with cetuximab would enhance the activity of chronotherapy as a result of improved circadian coordination...
Survival and recurrence of hepatitis C after liver transplantation in patients coinfected with human immunodeficiency virus and hepatitis C virusJean Charles Duclos-Vallée
Centre Hepato Biliaire, AP HP Hopital Paul Brousse, Villejuif, France
Hepatology 47:407-17. 2008....
Effects of 10 minutes of ischemic preconditioning of the cadaveric liver on the graft's preservation and function: the ying and the yangDaniel Azoulay
Centre Hepato Biliaire, Département de Chirurgie Hépato Biliaire, Hopital Paul Brousse, Villejuif, France
Ann Surg 242:133-9. 2005..Although extensively studied in animal models, ischemic preconditioning has not yet been studied in clinical transplantation...
Decision for retransplantation of the liver: an experience- and cost-based analysisDaniel Azoulay
Hepatobiliary Center, Hospital Paul Brousse, Assitance Publique Hôpitaux de Paris and Université Paris Sud, Villejuif, France
Ann Surg 236:713-21; discussion 721. 2002..To determine the patient factors affecting patient outcome of first liver retransplantation at a single center to help in the decision process for retransplantation...
Is hepatic resection justified after chemotherapy in patients with colorectal liver metastases and lymph node involvement?Rene Adam
Assistance Publique Hôpitaux de Paris Hôpital Paul Brousse, Centre Hepato Biliaire, 12 avenue Paul Vaillant Couturier, F 94804 Villejuif, France
J Clin Oncol 26:3672-80. 2008..The objective of this study was to evaluate the ability of a multidisciplinary approach, including preoperative chemotherapy and hepatectomy, to improve patient outcomes...
Complete pathologic response after preoperative chemotherapy for colorectal liver metastases: myth or reality?Rene Adam
AP HP Hopital Paul Brousse, Centre Hepato Biliaire, 12 avenue Paul Vaillant Couturier, F 94804 Villejuif, France
J Clin Oncol 26:1635-41. 2008..The objective of this study was to determine predictive factors of CPR as well as its impact on survival...
Impact of expanding criteria for resectability of colorectal metastases on short- and long-term outcomes after hepatic resectionRobbert J de Haas
AP HP Hopital Paul Brousse, Centre Hepato Biliaire, Villejuif, France
Ann Surg 253:1069-79. 2011..The aim of the present study was to ascertain this paradigm in an era of modern liver surgery...
Concomitant extrahepatic disease in patients with colorectal liver metastases: when is there a place for surgery?Rene Adam
AP HP Hopital Paul Brousse, Centre Hepato Biliaire, 12 avenue Paul Vaillant Couturier, Villejuif, France
Ann Surg 253:349-59. 2011....
Caval inflow to the graft for liver transplantation in patients with diffuse portal vein thrombosis: a 12-year experiencePrashant Bhangui
AP HP Hopital Paul Brousse, Centre Hepato Biliaire, Villejuif Cedex, France
Ann Surg 254:1008-16. 2011..To analyze the short- and long-term results of cavoportal anastomosis (CPA) and renoportal anastomosis (RPA) in 20 consecutive liver transplantation (LT) candidates with diffuse portal vein thrombosis (PVT)...
Patients with initially unresectable colorectal liver metastases: is there a possibility of cure?Rene Adam
AP HP Hopital Paul Brousse, Centre Hépato Biliaire and Department of Medical Oncology, Villejuif, France
J Clin Oncol 27:1829-35. 2009..The aim of this study was to evaluate long-term outcome after combining downsizing chemotherapy and rescue surgery and to define prognostic factors of cure...
Hepatic resection after rescue cetuximab treatment for colorectal liver metastases previously refractory to conventional systemic therapyRene Adam
Centre Hépato Biliaire and the Department of Medical Oncology, Assistance Publique Hopitaux de Paris, France
J Clin Oncol 25:4593-602. 2007..This study was performed to determine the post-cetuximab resectability rate and to examine postoperative outcomes for these heavily pretreated patients...
In situ hypothermic perfusion of the liver versus standard total vascular exclusion for complex liver resectionDaniel Azoulay
Centre Hepato Biliaire, Département de Chirurgie Hépato Biliaire, IFR 89 9, Hopital Paul Brousse, Villejuif, France
Ann Surg 241:277-85. 2005..The safe duration of TVE is still debated. Promising results have been reported following TVE associated with hypothermic perfusion of the liver with durations of up to several hours. The 2 techniques have not been compared so far...
Is liver resection justified for patients with hepatic metastases from breast cancer?Rene Adam
Centre Hepato Biliaire, Paul Brousse Hospital, Assistance Publique Hopitaux de Paris, Universite Paris Sud, 11 Villejuif, France
Ann Surg 244:897-907; discussion 907-8. 2006..The purpose of this study was to examine our experience with hepatic resection (HR) in a relatively unselected group of patients with breast cancer liver metastases (BCLM)...
Successful long-term outcome of ABO-incompatible liver transplantation using antigen-specific immunoadsorption columnsFaouzi Saliba
Hepatobiliary Center, Paul Brousse Hospital, Villejuif, France
Ther Apher Dial 14:116-23. 2010..Two patients are alive at 1.5 and 3 years follow-up with a normally functioning graft. The third patient died with a functioning graft, one month after the transplantation, from septic complications...
R1 resection by necessity for colorectal liver metastases: is it still a contraindication to surgery?Robbert J de Haas
AP HP Hopital Paul Brousse, Centre Hepato Biliaire, Villejuif, France
Ann Surg 248:626-37. 2008..To compare long-term outcome of R0 (negative margins) and R1 (positive margins) liver resections for colorectal liver metastases (CLM) treated by an aggressive approach combining chemotherapy and repeat surgery...
Long-term outcomes after hepatic resection for colorectal metastases in young patientsRobbert J de Haas
AP HP Hopital Paul Brousse, Centre Hepato Biliaire, Villejuif, France
Cancer 116:647-58. 2010..The aim of the current study was to evaluate long-term outcomes in patients < or = 40 years old, and to compare them with patients >40 years old...
[Auxiliary partial orthotopic liver transplantation using small grafts. A way to avoid small-for-size syndrome?]Olivier Scatton
Centre Hepato Biliaire, Hopital Paul Brousse, 12 avenue Paul Vaillant Couturier, 94800 Villejuif Cedex, France
Gastroenterol Clin Biol 29:76-9. 2005..With a follow-up of 5 years, the patient is in good condition. This original technique could be a solution to increase the number of transplantations using small grafts, especially left grafts, provided by splits or living donors...
Intention-to-treat analysis of liver transplantation for hepatocellular carcinoma: living versus deceased donor transplantationPrashant Bhangui
Hopital Paul Brousse, Assistance Publique Hopitaux de Paris, Villejuif, France
Hepatology 53:1570-9. 2011..Shorter waiting time preventing dropouts is an additional advantage with LDLT. LDLT for HCC patients beyond validated criteria should be proposed with caution...
Plasma disappearance rate of indocyanine green: a tool to evaluate early graft outcome after liver transplantationEric Levesque
AP HP Hopital Paul Brousse, Centre Hepato Biliaire, Villejuif, France
Liver Transpl 15:1358-64. 2009..8 to 10.3 +/- 2.5%/minute; P < 0.002). In conclusion, after LT, PDR-ICG (a noninvasive technique), measured regularly during the first 5 postoperative days, is a safe technique that can predict early postoperative complications...
Liver transplantation for hepatocellular carcinoma: the impact of human immunodeficiency virus infectionEric Vibert
Centre Hepato Biliaire, AP HP Hopital Paul Brousse, Villejuif, France
Hepatology 53:475-82. 2011..CONCLUSION: Because of a higher dropout rate among HIV+ patients, HIV infection impaired the results of LT for HCC on an intent-to-treat basis but had no significant impact on OS and RFS after LT...
Acquired KRAS mutations during progression of colorectal cancer metastases: possible implications for therapy and prognosisMohamed Bouchahda
Chronotherapy Unit and Department of Medical Oncology, Assistance Publique Hopitaux de Paris, Villejuif, France
Cancer Chemother Pharmacol 66:605-9. 2010..We report the first case of multiple KRAS mutations acquired during the metastatic phase of CRC, and retrospectively reviewed all patients with CRC, in whom KRAS was analyzed in at least two tumor samples from distinct lesions...
Liver transplantation for primary and metastatic liver cancersEmir Hoti
AP HP Hopital Paul Brousse, Centre Hepato Biliaire, Villejuif, France
Transpl Int 21:1107-17. 2008..Conversely, the value of transplantation for colorectal liver metastases (currently a contraindication) requires further evaluation by well-designed trials...
Therapeutic strategies in symptomatic portal biliopathyEric Vibert
Centre Hepato Biliaire, Hôpital Paul Brousse AP HP, Universite Paris Sud, Villejuif, France
Ann Surg 246:97-104. 2007..Because of the high hemorrhage risk associated with biliary surgery in patients with PC, the optimal therapeutic strategy is controversial...
Oxaliplatin plus irinotecan and FU-FOL combination and pharmacokinetic analysis in advanced colorectal cancer patientsMarian A Gil-Delgado
SOMPS, Salpetriere Hospital, Paris, France
Am J Clin Oncol 27:294-8. 2004..It would appear that the dose and schedule defined by this trial could be proposed as front-line therapy for advanced colorectal carcinoma to establish rapid disease control and to permit patients to proceed to surgery...
Resection of colorectal liver metastases with extrahepatic diseaseRobbert J de Haas
AP HP Hopital Paul Brousse, Centre Hepato Biliaire, Paris, France
Dig Surg 25:461-6. 2008..Long-term survival in these patients with advanced disease could be achieved if they are managed by experienced multidisciplinary teams...
Combined liver resection and reconstruction of the supra-renal vena cava: the Paul Brousse experienceDaniel Azoulay
Centre Hepato Biliaire, Hopital Paul Brousse, Villejuif, France
Ann Surg 244:80-8. 2006....
Oncologic results of laparoscopic versus open hepatectomy for colorectal liver metastases in two specialized centersDenis Castaing
AP HP Hopital Paul Brousse, Centre Hepato Biliaire, Villejuif F 94804, France
Ann Surg 250:849-55. 2009..Compare oncologic results of laparoscopic versus open hepatectomy for resection of colorectal metastases to the liver...
Rescue chemotherapy using multidrug chronomodulated hepatic arterial infusion for patients with heavily pretreated metastatic colorectal cancerMohamed Bouchahda
Chronotherapy Unit, Medical Oncology Department, Hepatobiliary Center, Public Assistance Hospital of Paris, Paul Brousse Hospital, Villejuif, France
Cancer 115:4990-9. 2009..In this article, the authors report their experience with chronomodulated HAI chemotherapy as rescue therapy in heavily pretreated patients who had metastatic colorectal cancer...
Evolution of neoadjuvant therapy for extended hepatic metastases--have we reached our (non-resectable) limit?Rene Adam
AP HP Hospital Paul Brousse, Centre Hepato Biliaire, Villejuif, France
J Surg Oncol 102:922-31. 2010..Bringing them together into an integrated framework has expanded the number of patients that can be treated with curative intent. This review focuses on recent oncosurgical changes, their impact, and future directions...
[Chemotherapy of liver metastasis from colorectal cancer]Henri Bismuth
Centre Hepato Biliaire, Hopital Paul Brousse, Assistance Publique Hopitaux de Paris, Faculte de Medecine Paris Sud, 12 avenue P V Couturier, 94800 Villejuif
Bull Acad Natl Med 191:1647-60; discussion 1660. 2007..New medical treatments, including monoclonal antibodies against tumoral growth factors (cetuximab) and vascular growth factors (bevacizumab), are also proving useful for tumor shrinkage prior to surgical resection...
Medical community preferences concerning adult living related donor liver transplantationDenis Castaing
Centre Hepato Biliaire, Hopital Paul Brousse, UPRES 1596, Universite Paris Sud, Villejuif
Gastroenterol Clin Biol 30:183-7. 2006..To assess acceptance and acceptable estimated mortality levels for right lobe adult-to-adult living related liver transplantation for the medical and allied professions...
[Increased long-term permeability of transjugular intrahepatic portosystemic shunt (TIPS) in 218 cirrhotic patients, with strict monitoring]Denis Castaing
Centre Hepato Biliaire, Hopital Paul Brousse, AP HP, Universite Paris Sud, Paris, Villejuif 94
Presse Med 33:1239-46. 2004..To measure the impact of strict monitoring on long term permeability of TIPS...
Longitudinal prospective evaluation of quality of life in adult patients before and one year after liver transplantationVincent Karam
Centre Hepatobiliaire, UPRES 1596, Assistance Publique Hopitaux de Paris, Universite Paris Sud, Hopital Paul Brousse, Villejuif, France
Liver Transpl 9:703-11. 2003..The results of transplant recipients were generally close to those of the general population. Although it is not a true return to normal status, it approaches it...
MDR1 polymorphism role in patients treated with cetuximab and irinotecan in irinotecan refractory colorectal cancerBernard Paule
Centre Hepatobiliaire, Department of Pharmacy Pharmacology, Paul Brousse University Hospital, AP HP, 12 14, avenue Paul Vaillant Couturier, Villejuif, France
Med Oncol 27:1066-72. 2010..Among patients resistant to irinotecan, it is still possible to use the association of cetuximab plus irinotecan to obtain a complete resection of hepatic metastases that is necessary to improve their survival...
Resection or transplantation for early hepatocellular carcinoma in a cirrhotic liver: does size define the best oncological strategy?Rene Adam
AP HP Hopital Paul Brousse, Centre Hépato Biliaire Université Paris Sud Inserm, Unité 785 Inserm, Unité 1004, Villejuif, France
Ann Surg 256:883-91. 2012..Resection and liver transplantation (LT) are the only curative options for hepatocellular carcinoma in cirrhotic patients (HCC-cirr)...
Results of percutaneous manoeuvres in biliary disease: the Paul Brousse experienceDenis Castaing
AP HP, Hopital Paul Brousse, Centre Hepato Biliaire, 12, avenue Paul Vaillant Couturier, 94804, Villejuif Cedex, France
Surg Endosc 25:1858-65. 2011..Percutaneous manoeuvres are alternatives to the endoscopic approach in the management of complex biliary disease...
Cetuximab plus gemcitabine-oxaliplatin (GEMOX) in patients with refractory advanced intrahepatic cholangiocarcinomasBernard Paule
Hepato Biliary Center, Assistance Publique Hopitaux de Paris, Hopital Paul Brousse, Faculté de Médecine Paris Sud 11, Villejuif, France
Oncology 72:105-10. 2007..To assess the efficacy and safety of cetuximab in the palliative treatment of patients with intrahepatic cholangiocarcinomas (CCA) unresponsive to first-line gemcitabine-oxaliplatin (GEMOX) pretreatment...
Liver transplantation: the current situationRene Adam
AP HP Hopital Paul Brousse, Centre Hepato Biliaire, Villejuif, France
Semin Liver Dis 29:3-18. 2009..This article discusses the utility of the mentioned techniques along with other strategies (e.g., Model for End-Stage Liver Disease [MELD] score), as well as the evolution of indications, contraindications, and postoperative care...
Two-stage hepatectomy approach for initially unresectable colorectal hepatic metastasesRene Adam
AP HP Hopital Paul Brousse, Centre Hepato Biliaire, 12 avenue Paul Vaillant Couturier, 94804 Villejuif, France
Surg Oncol Clin N Am 16:525-36, viii. 2007..This article describes strategic surgical approaches to multinodular metastatic disease and provides decision guidelines for two-stage hepatectomies...
Quality control of the European Liver Transplant Registry: results of audit visits to the contributing centersVincent Karam
Centre Hepatobiliaire, Hopital Paul Brousse, Villejuif, France vincent
Transplantation 75:2167-73. 2003..The number of registries is increasing, but few of them perform reliability audits by comparing the data contained in the database with data contained in hospital charts...
[Oncosurgical strategies for metastatic liver cancer]Rene Adam
AP HP Hopital Paul Brousse, Centre Hepato Biliaire, Villejuif, Francia
Cir Esp 89:10-9. 2011..In this review, we have described the current oncosurgical strategies employed in patients with resectable and non resectable CRLM, their benefits, and future treatment strategies...
[Liver transplantation with cavoportal or renoportal anastomosis: a solution in cases of diffuse portal thrombosis]Daniel Azoulay
Centre Hepato Biliaire, UPRES 1596, IFR 89 9, Hopital Paul Brousse, Villejuif Université Paris Sud, Paris, France
Gastroenterol Clin Biol 26:325-30. 2002..Long term results of these procedures are reported here...
Progression of alphafetoprotein before liver transplantation for hepatocellular carcinoma in cirrhotic patients: a critical factorE Vibert
AP HP, Hopital Paul Brousse, Centre Hepato Biliaire, INSERM, Unite 785, Universite Paris Sud, Villejuif, France
Am J Transplant 10:129-37. 2010..In conclusion, increasing AFP>15 microg/L/month while waiting for LT is the most relevant preoperative prognostic factor for low OS/DFS. AFP progression could be a pathological preoperative marker of tumor aggressiveness...
[Liver transplantation for intrahepatic Rendu-Osler-Weber's disease: the Paul Brousse hospital experience]Daniel Azoulay
Département de Chirurgie Hépato Biliaire, Hopital Paul Brousse, Universite Paris Sud, UPRES 1596, IFR 89 9, Villejuif, France
Gastroenterol Clin Biol 26:828-34. 2002..Nine centers have reported 15 cases of liver transplantation for Rendu-Osler-Weber's disease with liver involvement. Six cases are reported to analyse the specific technical and hemodynamical aspects...
Phase III multicenter randomized trial of oxaliplatin added to chronomodulated fluorouracil-leucovorin as first-line treatment of metastatic colorectal cancerS Giacchetti
International Organization of Cancer Chronotherapy, Centre de Chronothérapie, Hopital Paul Brousse, Villejuif, France
J Clin Oncol 18:136-47. 2000..To study how adding oxaliplatin (l-OHP) to chronomodulated fluorouracil (5-FU)-leucovorin (LV) affected the objective response rate, as first-line treatment of metastatic colorectal cancer...
Auxiliary partial orthotopic versus standard orthotopic whole liver transplantation for acute liver failure: a reappraisal from a single center by a case-control studyD Azoulay
Hepatobiliary Surgery and Liver Transplant Unit, UPRES 1596, IFR 89 9, Hopital Paul Brousse, Universite Paris Sud, 94804 Villejuif, France
Ann Surg 234:723-31. 2001..To reappraise the results of auxiliary partial orthotopic liver transplantation (APOLT) compared with those of standard whole-liver transplantation (OLT) in terms of postoperative death and complications, including neurologic sequelae...
[Adult to adult living-related liver transplantation. The Paul-Brousse Hospital preliminary experience]D Azoulay
Centre Hepato Biliaire, Hopital Paul Brousse, UPRES 1596, IFR 89 9, Universite Paris Sud, Villejuif, France
Gastroenterol Clin Biol 25:773-80. 2001..Follow-up ranged from 41 to 157 days (median: 117 days)...
[Training of residents in surgery: need for contractual agreement]D Castaing
, , Villejuif
J Chir (Paris) 139:46-9. 2002
Chemotherapy and surgery: new perspectives on the treatment of unresectable liver metastasesR Adam
, Hopital Paul Brousse, Villejuif, Paris, France
Ann Oncol 14:ii13-6. 2003..The poor prognosis of patients with non-resectable hepatic metastases might now be improved by the combination of chemotherapy and surgery...
[Multistage liver resections in colorectal liver metastases. The Paul Brousse concept]D Azoulay
Centre Hepato Biliaire, Hopital Paul Brousse, France
Chirurg 72:765-9. 2001..The aim of this paper is to report the strategies we use in our center to achieve curative resection in these three schematic situations despite initial contraindications...
Liver transplantation for hepatocellular carcinomaH Bismuth
Centre Hepatobiliaire, Universite Paris Sud, Hopital Paul Brousse, Villejuif, France
Semin Liver Dis 19:311-22. 1999..Resection may be indicated if the waiting time is likely to be long...
Hepatocellular carcinoma with lymphoid stroma: a tumour with good prognosis after liver transplantationJ F Emile
Service d Anatomopathologie, Centre Hepatobiliaire, Hôpital Paul Brousse and UPRES 1596 Virus Hépatotropes et Cancer, Universite Paris Sud, France
Histopathology 37:523-9. 2000..We determined the frequency, characteristics and prognosis of hepatocellular carcinomas with lymphoid stroma...
Split-liver transplantation for two adult recipients: feasibility and long-term outcomesD Azoulay
Centre Hepatobiliaire, UPRES 1596, Assistance Publique Hopitaux de Paris, Universite Paris Sud, Hopital Paul Brousse, Villejuif, France
Ann Surg 233:565-74. 2001..To identify the outcomes and risks of split-liver transplantation (SLT) for two adult recipients to determine the feasibility of more widespread use of this procedure to increase the graft pool for adults...
[Severe visual loss due to retinal artery occlusion associated with Susac's syndrome: a case report]B Bodaghi
Service d Ophtalmologie, CHU Pitie Salpetriere, Paris
Rev Neurol (Paris) 161:1221-4. 2005..Susac's syndrome consists of the clinical triad of cerebral microangiopathy, branch retinal artery occlusions, and hearing loss. The pathogenesis of the disease remains unknown. The severity of retinal vasculopathy remains variable...
[Percutaneous destruction of hepatic tumors]E Savier
, , Paris
J Chir (Paris) 140:100-3. 2003
Bringing unresectable liver disease to resection with curative intentD A Wicherts
AP HP Hopital Paul Brousse, Centre Hepato Biliaire, Villejuif F 94804, France
Eur J Surg Oncol 33:S42-51. 2007..Overall, surgery should be performed as soon as liver metastases become resectable. Collaboration between oncologists and surgeons is essential to optimize individual therapeutic strategies...
[New surgical strategies for liver metastasis of colorectal cancer: report of 3 cases]G Pascal
, , Villejuif, France
Ann Chir 128:5-8. 2003
Importance of conserving middle hepatic vein distal branches for homogeneous regeneration of the left liver after right hepatectomyFrancois Faitot
Hepatobiliary Centre Unit 785, INSERM, University of Paris South, Villejuif, France
HPB (Oxford) 14:746-53. 2012..This study examined left liver regeneration after right hepatectomy and the impact of hepatic venous drainage on the regeneration of the paramedian sector (Couinaud's segment IV)...
Strategies to treat primary unresectable colorectal liver metastasesEric Vibert
, , , , Villejuif, France
Semin Oncol 32:33-9. 2005..The development of new chemotherapy protocols that offer the potential for curative surgery with optimum timing within the natural history of this metastatic disease is a shared therapeutic challenge...
Hepatic resection for noncolorectal nonendocrine liver metastases: analysis of 1,452 patients and development of a prognostic modelRene Adam
Paul Brousse Hospital, Villejuif, France
Ann Surg 244:524-35. 2006..To determine the utility of hepatic resection (HR) in the treatment of patients with noncolorectal nonendocrine liver metastases (NCNELM)...
Hepatitis C virus viral recurrence and liver mitochondrial damage after liver transplantation in HIV-HCV co-infected patientsJean Charles Duclos-Vallée
Centre Hépato Biliaire Hôpital Paul Brousse, Assistance Publique Hopitaux de Paris, 94804 Villejuif, France
J Hepatol 42:341-9. 2005..We report the Paul Brousse Hospital experience of transplantation for end stage cirrhosis in HIV-HCV co-infected patients...
[Alcoholic liver cirrhosis. Treatment of hepatocellular carcinoma]L A Veilhan
, , Villejuif
Presse Med 30:1170-7. 2001..The management of patients with HCC with or without cirrhosis may combine several treatment modalities and needs a multi-disciplinary approach...
Comparison of simultaneous or delayed liver surgery for limited synchronous colorectal metastasesR J de Haas
Hepato Biliary Centre, Hopital Paul Brousse, Assistance Publique Hopitaux de Paris, France
Br J Surg 97:1279-89. 2010..The aim of this study was to compare simultaneous colorectal and hepatic resection with a delayed strategy in patients who had a limited hepatectomy (fewer than three segments)...
Colorectal cancer with synchronous liver metastasesR Adam
, Paul Brousse Hospital, , , Villejuif, Paris, France
Br J Surg 94:129-31. 2007
Regional treatment of metastasis: surgery of colorectal liver metastasesR Adam
, Hopital Paul Brousse, , Villejuif, France
Ann Oncol 15:iv103-6. 2004
[Resection of liver metastasis of colorectal origin following chemotherapy with irinotecan]R Adam
, , 94800 Villejuif, France
Ann Chir 129:2-4. 2004
Impact of portal vein embolization on long-term survival of patients with primarily unresectable colorectal liver metastasesD A Wicherts
Centre Hepato Biliaire, Assistance Publique Hopitaux de Paris, Hopital Paul Brousse, Villejuif, France
Br J Surg 97:240-50. 2010..Portal vein embolization (PVE) increases the resectability of initially unresectable colorectal liver metastases (CLM). This study evaluated long-term survival in patients with CLM who underwent hepatectomy following PVE...
Prospective phase II trial of iriontecan, 5-fluorouracil, and leucovorin in combination as salvage therapy for advanced colorectal cancerM A Gil-Delgado
Department of Medical Oncology, , Paris, France
Am J Clin Oncol 24:101-5. 2001..Efficacy in this poor prognosis group of patients is very encouraging, and the schedule is well tolerated by even previously treated patients...
Long-term outcome in patients with adrenal metastases following resection of colorectal liver metastasesR J de Haas
Assistance Publique Hopitaux de Paris, Hopital Paul Brousse, Centre Hepato Biliaire, Villejuif, France
Br J Surg 96:935-40. 2009..The aim of this study was to determine the influence of AMs on long-term outcome and the role of adrenalectomy in patients with CLMs...
[A new concept: induction chemotherapy in liver metastasis of colorectal origin]R Adam
, , 94800 Villejuif, France
Ann Chir 129:1. 2004
[23-gauge transconjunctival sutureless vitrectomy: a retrospective study of 164 consecutive cases]N de Preobrajensky
CHNO des Quinze vingt, 28, rue de Charenton, Paris, France
J Fr Ophtalmol 33:99-104. 2010..To describe our initial experience and to evaluate the outcomes of patients treated with 23-gauge transconjunctival sutureless vitrectomy for a variety of vitreoretinal conditions...
Toward optimized front-line therapeutic strategies in patients with metastatic colorectal cancer--an expert review from the International Congress on Anti-Cancer Treatment (ICACT) 2009R Adam
Centre Hepato Biliaire, University Paris Sud, Unité 776, Villejuif, France
Ann Oncol 21:1579-84. 2010..The objectives of this expert conference were to review the different options, the available prognostic or predictive factors to optimally guide the treatment...
Phase I-II study of irinotecan in combination with mitomycin C in patients with advanced gastrointestinal cancerM A Gil-Delgado
Department of Medical Oncology, , Paris, France
Am J Clin Oncol 24:251-4. 2001..Evidence of efficacy was seen at all dose levels examined and justifies further exploration of this combination in a less heavily pretreated patient population...
Immunohistochemical variability of epidermal growth factor receptor (EGFR) in liver metastases from colonic carcinomasM P Bralet
Department of Pathology, APHP, Paul Brousse Hospital, Villejuif, France
Histopathology 50:210-6. 2007....
Hepatic resection for metastatic renal tumors: is it worthwhile?A Alves
Centre Hepato Biliaire, Hopital Paul Brousse, Universite Paris Sud, Villejuif, France
Ann Surg Oncol 10:705-10. 2003..Little is known of the outcome of isolated metastases to the liver for which resection is potentially curative...
